Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2022-01-03 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
Disposal - 03.01.22 - ENG.pdf
Transaction in Own Shares Classification · 99% confidence The document is explicitly titled "Disposals of own shares" and details transactions where UCB disposed of its own shares OTC, primarily related to the exercise of stock options and vesting of Long Term Incentive (LTI) plans. This activity directly corresponds to the definition of 'Transaction in Own Shares'. The filing code for this activity is POS.
2022-01-03 English
Disposal - 03.01.22 - FR.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Aliénation d'actions propres" (Alienation of own shares) and the content details transactions where UCB SA alienated (sold/transferred) its own shares following option exercises by employees and free delivery under Long-Term Incentive (LTI) plans. This directly corresponds to the definition of a company reporting transactions involving its own shares, specifically share repurchase or issuance/transfer. The appropriate code is POS (Transaction in Own Shares). The document is a formal regulatory announcement dated January 3, 2022, concerning transactions that occurred in late December 2021.
2022-01-03 French
Disposal - 03.01.22 - NL.pdf
Transaction in Own Shares Classification · 99% confidence The document title is "Vervreemding van eigen aandelen" (Disposal of own shares) and the content details transactions where UCB shares were delivered to employees as part of long-term incentive plans (LTI plans) and stock option plans. This involves the company dealing in its own shares, specifically through delivery/transfer rather than open market purchase/sale, but the core activity is related to the company's own share capital management. This aligns directly with the definition for 'Transaction in Own Shares' (POS), which covers share repurchase/issuance activities. Although the text mentions 'gereglementeerde informatie' (regulated information), the specific subject matter points strongly to POS over a general RNS filing. The document length is short (2301 chars), but it contains the substantive details of the transaction, not just an announcement that a report is attached, thus it is classified as the transaction report itself.
2022-01-03 Dutch
211221 - Disposals of own shares_ENG.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Disposals of own shares" and details the transaction of UCB shares OTC following the exercise of stock options under Long Term Incentive Programs. This directly relates to the company buying back or issuing its own shares, which corresponds to the definition of 'Transaction in Own Shares'. The filing code for this is POS. The document is short and contains specific transaction details, confirming it is the primary announcement, not just a notice of publication.
2021-12-21 English
211221 - Aliénation d'actions propres_FR.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Aliénation d'actions propres" (Disposal of own shares) and explicitly states that UCB SA is making public the alienation of UCB shares following the exercise of options by personnel, as required by Belgian Royal Decree Article 8:6. This action involves the company buying back or selling its own shares for employee compensation purposes. This directly matches the definition for 'Transaction in Own Shares' (POS). The document is short and contains the announcement itself, not just a link to a larger report.
2021-12-21 French
211221 - Vervreemding van eigen aandelen_NED.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled "Vervreemding van eigen aandelen" (Disposal of own shares) and details transactions where UCB shares were delivered to employees as part of long-term incentive plans following option exercises. This directly relates to the company buying back or issuing its own shares, specifically in the context of employee compensation/incentives, which falls under the definition of 'Transaction in Own Shares'. The code for this is POS. The document is a formal announcement (gereglementeerde informatie) detailing specific transaction dates, quantities, and prices.
2021-12-21 Dutch

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.